These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9847269)

  • 1. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of skin test antigens to evaluate PPD anergy.
    Wright PW; Crutcher JE; Holiday DB
    J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group.
    Chin DP; Osmond D; Page-Shafer K; Glassroth J; Rosen MJ; Reichman LB; Kvale PA; Wallace JM; Poole WK; Hopewell PC
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1982-4. PubMed ID: 8665065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
    Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
    Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis.
    MMWR Recomm Rep; 1991 Apr; 40(RR-5):27-32. PubMed ID: 2034206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for developing tuberculosis among anergic patients infected with HIV.
    Moreno S; Baraia-Etxaburu J; Bouza E; Parras F; Pérez-Tascón M; Miralles P; Vicente T; Alberdi JC; Cosín J; López-Gay D
    Ann Intern Med; 1993 Aug; 119(3):194-8. PubMed ID: 8100693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of tuberculin skin reaction with lymphocyte proliferation, interferon-gamma production and tumor necrosis factor-alpha production after in vitro stimulation with PPD and killed Mycobacterium tuberculosis using peripheral blood of healthy donors].
    Kitsukawa K; Nakamoto A; Saito A
    Kekkaku; 1992 Jul; 67(7):521-8. PubMed ID: 1434316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the risk of tuberculosis among HIV-infected patients.
    Guelar A; Gatell JM; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró JM; Mallolas J; Zamora L; González J
    AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE; Schein MF; Hall CA; Barnes SA
    Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.
    Johnson DF; Malone LL; Zalwango S; Mukisa Oketcho J; Chervenak KA; Thiel B; Mayanja-Kizza H; Stein CM; Boom WH; Lancioni CL;
    PLoS One; 2014; 9(5):e96613. PubMed ID: 24796677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection.
    Villarino ME; Geiter LJ; Schulte JM; Castro KG
    AIDS; 1994 Apr; 8(4):477-81. PubMed ID: 8011250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults.
    Lim HJ; Okwera A; Mayanja-Kizza H; Ellner JJ; Mugerwa RD; Whalen CC
    HIV Clin Trials; 2006; 7(4):172-83. PubMed ID: 17065029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration.
    Whalen C; Okwera A; Johnson J; Vjecha M; Hom D; Wallis R; Huebner R; Mugerwa R; Ellner J
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1977-81. PubMed ID: 8665064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).
    Antonucci G; Girardi E; Raviglione MC; Ippolito G
    JAMA; 1995 Jul; 274(2):143-8. PubMed ID: 7596002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid chemoprophylaxis.
    Tager IB; Kalaidjian R; Baldini L; Rocklin RE
    Am Rev Respir Dis; 1985 Feb; 131(2):214-20. PubMed ID: 3882032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.